5.31

1.85% -0.10

After Hours: 5.26 -0.05 -0.94%

Artelo Biosciences Inc (ARTL)

Overview News Price History Financials Discussions Forecast Stock Split

Artelo Biosciences Inc stock is traded at $5.31, with a volume of 183.12K. It is down -1.85% in the last 24 hours and up +41.22% over the past month. Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Previous Close:

$5.41

Open:

$5.3

24h Volume:

183.12K

Relative Volume:

0.07

Market Cap:

$4.34M

Revenue:

Net Income/Loss:

$-12.88M

P/E Ratio:

-0.149

EPS:

-35.6417

Net Cash Flow:

$-8.79M

1W Performance:

-22.37%

1M Performance:

+41.22%

6M Performance:

-57.86%

1Y Performance:

-71.36%

1-Day Range:

$5.14

$5.4745

1-Week Range:

$5.08

$6.91

52-Week Range:

$2.955

$85.80

Artelo Biosciences Inc Stock (ARTL) Company Profile

Name

Artelo Biosciences Inc

Sector

Healthcare (1112)

Industry

Biotechnology (621)

Phone

858-925-7049

Address

505 LOMAS SANTA FE, SUITE 160, SOLANA BEACH, CA

Employee

Twitter

@ArteloBio

Next Earnings Date

2024-12-11

Latest SEC Filings

ARTL's Discussions on Twitter

Compare ARTL vs VRTX, REGN, ARGX, ALNY, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ARTL Artelo Biosciences Inc	5.31	4.42M	0	-12.88M	-8.79M	-35.64
VRTX Vertex Pharmaceuticals Inc	441.70	113.01B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	753.93	79.87B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	840.87	51.51B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	333.39	45.29B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	319.94	34.41B	5.36B	287.73M	924.18M	2.5229

Artelo Biosciences Inc Stock (ARTL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-08-25	Upgrade	D. Boral Capital	Hold → Buy
Feb-12-21	Initiated	Ladenburg Thalmann	Buy

Artelo Biosciences Inc Stock (ARTL) Latest News

Apr 13, 2026

Aug Wrap: What is the cash position of Artelo Biosciences Inc2026 Setups & Daily Market Momentum Tracking - baoquankhu1.vn

Apr 08, 2026

Panic Selling: What is the cash position of Artelo Biosciences IncQuarterly Performance Summary & Weekly Setup with ROI Potential - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Artelo Biosciences regains Nasdaq listing compliance By Investing.com - Investing.com Australia

Apr 07, 2026

Artelo Biosciences Files Offering for 9.8 Million Common Stock; Shares Tumble - marketscreener.com

Apr 07, 2026

9.8M Artelo Biosciences (ARTL) shares registered for resale after March 2026 PIPE - Stock Titan

Apr 07, 2026

Artelo Biosciences Regains Compliance With Nasdaq Listing Requirements - Moomoo

Apr 07, 2026

Artelo Biosciences regains Nasdaq listing compliance - Investing.com

Apr 07, 2026

Artelo Biosciences Regains Nasdaq Compliance and Advances Clinical Pipeline for Cancer and Pain Treatments - Minichart

Apr 07, 2026

Why Is ARTL Stock Soaring Pre-Market Today? - Stocktwits

Apr 07, 2026

Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements - The Manila Times

Apr 07, 2026

Artelo Biosciences regains Nasdaq compliance, subject to one-year panel monitor - TradingView — Track All Markets

Apr 07, 2026

Artelo Biosciences (NASDAQ: ARTL) regains full Nasdaq listing compliance - Stock Titan

Apr 07, 2026

Artelo Biosciences Regains Compliance with Nasdaq Listing Rules - Quiver Quantitative

Apr 07, 2026

Artelo Biosciences stock soars after withdrawing SEC filing - MSN

Apr 07, 2026

Apr 06, 2026

Artelo Biosciences Secures $11M in Funding, Extending Runway, Yet Spending Pace and Key Clinical Goals Still Take Center Stage - Bitget

Apr 06, 2026

Apr 03, 2026

Artelo Biosciences (ARTL) joint holders report 9.99% stake, warrants blocked - Stock Titan

Apr 03, 2026

Apr 02, 2026

ARTL, BFRG, HKIT among stocks soaring before the bell — top pre-market gainers today - MSN

Apr 02, 2026

ARTL Stock Chart | ARTELO BIOSCIENCES INC (NASDAQ:ARTL) - ChartMill

Apr 02, 2026

Mar 31, 2026

Spotlight Movers: APLS, VTIX, ELAB, ARTL Fuel Multi-Sector Momentum - Barchart.com

Mar 31, 2026